Sanja Dabelić

1.6k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Sanja Dabelić is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Sanja Dabelić has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Sanja Dabelić's work include Galectins and Cancer Biology (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Signaling Pathways in Disease (4 papers). Sanja Dabelić is often cited by papers focused on Galectins and Cancer Biology (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Signaling Pathways in Disease (4 papers). Sanja Dabelić collaborates with scholars based in Croatia, Germany and Austria. Sanja Dabelić's co-authors include Jerka Dumić, Mirna Flögel, Ruđer Novak, Gordan Lauc, Jerka Dumić, Ivana Vinković Vrček, Rinea Barbir, Rafael Martín‐Rapún, Jesús M. de la Fuente and Tihomir Balog and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Annals of the New York Academy of Sciences.

In The Last Decade

Sanja Dabelić

34 papers receiving 1.3k citations

Hit Papers

Galectin-3: An open-ended story 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanja Dabelić Croatia 13 939 681 251 129 63 37 1.3k
Jerka Dumić Croatia 12 943 1.0× 619 0.9× 243 1.0× 123 1.0× 82 1.3× 26 1.3k
Inna M. Yasinska United Kingdom 21 740 0.8× 562 0.8× 301 1.2× 48 0.4× 53 0.8× 38 1.5k
Zhu Chen China 19 408 0.4× 515 0.8× 215 0.9× 91 0.7× 34 0.5× 44 1.4k
Ernesta Palombo‐Kinne Germany 14 350 0.4× 372 0.5× 237 0.9× 70 0.5× 24 0.4× 20 1.2k
Junfeng Zhang China 18 573 0.6× 442 0.6× 282 1.1× 38 0.3× 62 1.0× 57 1.2k
Qiang Zhu China 19 324 0.3× 604 0.9× 137 0.5× 115 0.9× 135 2.1× 74 1.2k
Magdalena Jarosz–Biej Poland 15 267 0.3× 362 0.5× 321 1.3× 108 0.8× 126 2.0× 31 974
Stewart Abbot United Kingdom 19 381 0.4× 345 0.5× 281 1.1× 178 1.4× 41 0.7× 28 1.0k
Michelle M. Appenheimer United States 14 593 0.6× 443 0.7× 518 2.1× 60 0.5× 80 1.3× 16 1.3k

Countries citing papers authored by Sanja Dabelić

Since Specialization
Citations

This map shows the geographic impact of Sanja Dabelić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanja Dabelić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanja Dabelić more than expected).

Fields of papers citing papers by Sanja Dabelić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanja Dabelić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanja Dabelić. The network helps show where Sanja Dabelić may publish in the future.

Co-authorship network of co-authors of Sanja Dabelić

This figure shows the co-authorship network connecting the top 25 collaborators of Sanja Dabelić. A scholar is included among the top collaborators of Sanja Dabelić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanja Dabelić. Sanja Dabelić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dabelić, Sanja, et al.. (2024). Quality Assessment of Cryopreserved Peripheral Blood Stem Cell Products: Evaluation of Two Methods for Flow Cytometric Viability Testing. International Journal of Laboratory Hematology. 47(1). 93–100.
2.
Barbarić, Monika, Ana Mornar, Daniela Amidžić Klarić, et al.. (2023). Oleuropein in olive leaf, branch, and stem extracts: stability and biological activity in human cervical carcinoma and melanoma cells. Acta Pharmaceutica. 73(4). 601–616. 3 indexed citations
3.
Tadić, Vanja, George E. Durán, Sanja Dabelić, et al.. (2023). Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer. Cellular and Molecular Life Sciences. 80(10). 294–294. 10 indexed citations
4.
Dabelić, Sanja, et al.. (2022). Extra Virgin Olive Oil Secoiridoids Modulate the Metabolic Activity of Dacarbazine Pre-Treated and Treatment-Naive Melanoma Cells. Molecules. 27(10). 3310–3310. 8 indexed citations
5.
Ćurlin, Marija, Rinea Barbir, Sanja Dabelić, et al.. (2021). Sex affects the response of Wistar rats to polyvinyl pyrrolidone (PVP)-coated silver nanoparticles in an oral 28 days repeated dose toxicity study. Particle and Fibre Toxicology. 18(1). 38–38. 11 indexed citations
6.
Bernat, Robert, et al.. (2020). Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease. Journal of Medical Biochemistry. 40(2). 138–149. 3 indexed citations
7.
Dabelić, Sanja, et al.. (2016). Association of 1166A>C AT 1 R , -1562C>T MMP-9 , ACE I/D , and CCR5 Δ32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients. Genetic Testing and Molecular Biomarkers. 20(10). 616–623. 4 indexed citations
8.
Kos, Ivan, et al.. (2013). Synthesis, antibacterial and cytotoxic activity evaluation of hydroxyurea derivatives. Acta Pharmaceutica. 63(2). 175–191. 7 indexed citations
9.
Dabelić, Sanja, et al.. (2012). Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells. In Vitro Cellular & Developmental Biology - Animal. 48(8). 518–527. 16 indexed citations
10.
Dabelić, Sanja, et al.. (2012). Insights into complexity of congenital disorders of glycosylation. Biochemia Medica. 22(2). 156–170. 32 indexed citations
12.
Novak, Ruđer, Sanja Dabelić, & Jerka Dumić. (2011). Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(9). 1383–1390. 68 indexed citations
13.
Dabelić, Sanja, et al.. (2011). Employment of single‐strand conformation polymorphism analysis in screening for α‐1,3 glucosyltransferase gene mutation A333V in Croatian population. Journal of Clinical Laboratory Analysis. 25(2). 65–70. 3 indexed citations
14.
Dabelić, Sanja, et al.. (2005). GALECTIN-3 EXPRESSION IS AFFECTED BY GLUCOCORTICOIDS. Glycoconjugate Journal. 22. 347. 1 indexed citations
15.
Dabelić, Sanja, Mirna Flögel, & Jerka Dumić. (2005). Effects of aspirin and indomethacin on galectin-3. Croatica Chemica Acta. 78(3). 433–440. 6 indexed citations
16.
Dabelić, Sanja, et al.. (2005). Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1760(4). 701–709. 21 indexed citations
17.
Dumić, Jerka, Sanja Dabelić, & Mirna Flögel. (2002). Curcumin – A Potent Inhibitor of Galectin-3 Expression. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Dumić, Jerka, Sanja Dabelić, & Mirna Flögel. (2002). Kurkumin – snažan inhibitor ekspresije galektina-3. Food Technology and Biotechnology. 40(4). 281–287. 3 indexed citations
19.
Lauc, Gordan, Sanja Dabelić, Jerka Dumić, & Mirna Flögel. (1998). Stressin and Natural Killer Cell Activity in Professional Soldiersa. Annals of the New York Academy of Sciences. 851(1 STRESS OF LIF). 526–530. 12 indexed citations
20.
Lauc, Gordan, et al.. (1998). Glycobiology of Stressa. Annals of the New York Academy of Sciences. 851(1 STRESS OF LIF). 397–403. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026